Find a Biotech job in Boston

Amgen appoints Harvard business professor to board

Biotechnology company Amgen Inc. said Friday that Rebecca Henderson has been appointed to the board of directors. (AP, 7/10/09)

Johnson & Johnson completes Cougar Biotech deal

Johnson & Johnson said Friday it completed its $893.7 million acquisition of Cougar Biotechnology Inc., a development stage company that is testing a potential treatment for prostate cancer. (AP, 7/10/09)

Genzyme patients not negatively affected by production halt, they say

A nearly monthlong halt in the production of two drugs that treat rare genetic disorders has not yet caused significant hardship for those who depend on the treatments, according to patients and advocates. (Boston Globe, 7/10/09)

Biogen MS drug on track

Biogen Idec Inc., a Cambridge company known for its multiple sclerosis drugs, said the US Food and Drug Administration has granted it fast-track designation for a potential treatment of relapsing multiple sclerosis. (Boston Globe, 7/9/09)

Drug maker takes over firm’s goats

GTC Biotherapeutics Inc. , a Framingham company that made news in February by becoming the first biotechnology firm to win federal approval to manufacture a drug by using genetically modified animals, said it will assume control of transgenic goats that had been developed for Merrimack Pharmaceuticals Inc., a privately held Cambridge company. (Boston Globe, 7/9/09)